-
About FDA
-
November 3 Public Meeting on Transparency: Hypothetical Case Studies
Below are links to the complete hypothetical case studies discussed by participants at the public meeting on November 3.
- Emerging Safety Issues Concerning FDA-Regulated Products
- Product Applications That Are Abandoned or Withdrawn by the Applicant Before Approval
- Agency Decisions About Pending Product Applications
-
-

